Thomas Balligand, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calreticulin | 5 | 2023 | 97 | 1.560 |
Why?
|
| Receptors, Thrombopoietin | 5 | 2023 | 156 | 1.200 |
Why?
|
| Thrombocythemia, Essential | 1 | 2019 | 103 | 0.640 |
Why?
|
| Janus Kinase 2 | 3 | 2023 | 527 | 0.610 |
Why?
|
| STAT5 Transcription Factor | 1 | 2016 | 259 | 0.520 |
Why?
|
| Exons | 1 | 2019 | 2431 | 0.450 |
Why?
|
| Heart | 1 | 2019 | 4462 | 0.270 |
Why?
|
| Frameshift Mutation | 2 | 2019 | 399 | 0.270 |
Why?
|
| Zanamivir | 1 | 2023 | 21 | 0.230 |
Why?
|
| Hematoxylin | 1 | 2021 | 64 | 0.200 |
Why?
|
| Myeloproliferative Disorders | 2 | 2023 | 603 | 0.170 |
Why?
|
| Thrombocytosis | 1 | 2019 | 81 | 0.170 |
Why?
|
| Signal Transduction | 3 | 2023 | 23387 | 0.160 |
Why?
|
| Receptors, Cytokine | 1 | 2019 | 261 | 0.160 |
Why?
|
| Receptors, Erythropoietin | 1 | 2017 | 147 | 0.150 |
Why?
|
| Primary Myelofibrosis | 1 | 2019 | 214 | 0.150 |
Why?
|
| Polycythemia | 1 | 2017 | 126 | 0.140 |
Why?
|
| Homozygote | 1 | 2019 | 1777 | 0.120 |
Why?
|
| Hydroxylysine | 1 | 2012 | 5 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2023 | 1472 | 0.100 |
Why?
|
| Ethanolamines | 1 | 2012 | 158 | 0.100 |
Why?
|
| Transaminases | 1 | 2012 | 199 | 0.100 |
Why?
|
| Hematopoiesis | 1 | 2019 | 2066 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 1786 | 0.090 |
Why?
|
| Mice | 7 | 2023 | 81045 | 0.080 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 1820 | 0.070 |
Why?
|
| Genome, Bacterial | 1 | 2012 | 754 | 0.070 |
Why?
|
| Cell Line | 4 | 2023 | 15994 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 2940 | 0.070 |
Why?
|
| Animals | 8 | 2023 | 168561 | 0.060 |
Why?
|
| Oseltamivir | 1 | 2023 | 75 | 0.060 |
Why?
|
| Neuraminidase | 1 | 2023 | 210 | 0.050 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2023 | 276 | 0.050 |
Why?
|
| Mutation | 6 | 2023 | 29717 | 0.050 |
Why?
|
| Bacteria | 1 | 2012 | 2102 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2023 | 1245 | 0.040 |
Why?
|
| Genome, Human | 1 | 2012 | 4420 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2012 | 3843 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2021 | 1723 | 0.040 |
Why?
|
| Protein Stability | 1 | 2017 | 556 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2017 | 500 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2019 | 742 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2023 | 6382 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 21596 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2023 | 1575 | 0.030 |
Why?
|
| Erythropoietin | 1 | 2017 | 724 | 0.030 |
Why?
|
| Protein Transport | 1 | 2019 | 1988 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2021 | 1057 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2017 | 971 | 0.030 |
Why?
|
| Binding Sites | 1 | 2021 | 6115 | 0.030 |
Why?
|
| Protein Binding | 1 | 2021 | 9387 | 0.020 |
Why?
|
| Humans | 8 | 2023 | 742088 | 0.020 |
Why?
|
| Cytokines | 1 | 2023 | 7317 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2012 | 2837 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 13814 | 0.020 |
Why?
|
| Male | 1 | 2019 | 349538 | 0.010 |
Why?
|
| Female | 1 | 2019 | 379592 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 2012 | 5024 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2012 | 6874 | 0.010 |
Why?
|